How a Multinational Biopharma Used PAT to Shift From Batch to Continuous Manufacturing

Pharma companies continue to strive for tight control of critical quality attributes (CQAs). When Ferring Pharmaceuticals wanted to move from batch to continuous manufacturing, they found that laboratory assays were too time consuming to provide meaningful feedback for real-time control, and 100% product quality inspection was not possible.

In this on-demand webinar, learn how Ferring implemented Process Analytical Technology (PAT) to provide real-time process control enabling them to:

  • Use spectral data pretreatment and multivariate modeling to ensure accurate and reproducible prediction of CQAs in real-time, eliminating laborious laboratory testing
  • Obtain real-time feedback on quality deviations for closed-loop control to automatically adjust API dosing rate and regulate CQAs
  • Leverage online measurement to allow 100% product quality inspection and real-time release testing, a key enabler for continuous manufacturing

Discover how Ferring used state-of-the-art PAT to enable the shift from batch to continuous manufacturing, which boosts production efficiency and consistency.

How a Multinational Biopharma Used PAT to Shift From Batch to Continuous Manufacturing

Why we collect this data:

AspenTechは、当社の事業、可能な限り最善の製品やカスタマーサービスのご提供、そして全体的なユーザエクスペリエンスに関わるさまざまな理由でお客様の個人データを収集および処理する場合があります。当社はお客様の個人データを使用して適宜、アンケートや調査の管理、契約サービスの正確な提供、イベントへの登録、お客様の好みの理解、および不正または不正な活動の検出と防止を行う場合があります。個人データの収集と処理の詳細については、こちらからAspenTechのプライバシーおよびセキュリティポリシーを参照してください。

How a Multinational Biopharma Used PAT to Shift From Batch to Continuous Manufacturing

Hello . If this is not you

Thank you for viewing this on-demand webinar

If you weren't redirected, click here